v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:    
Research and development $ 101,200 $ 75,473
General and administrative 26,024 18,808
Total operating expenses 127,224 94,281
Interest income, net (6,337) (7,180)
Other income, net (1,187) (28)
Loss before provision for income taxes (119,700) (87,073)
Provision for income taxes 913 77
Net loss $ (120,613) $ (87,150)
Net loss per common share - basic (in dollars per share) $ (0.71) $ (0.60)
Net loss per common share - diluted (in dollars per share) $ (0.71) $ (0.60)
Weighted-average common shares outstanding – basic (in shares) 170,872,994 146,085,729
Weighted-average common shares outstanding – diluted (in shares) 170,872,994 146,085,729